Francesco Gianfagna Selected Research

Francesco Gianfagna Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2012
5	COVID-19 05/2023 - 01/2021
5	Atrial Fibrillation 05/2023 - 10/2013
5	Inflammation (Inflammations) 01/2023 - 09/2008
5	Stomach Neoplasms (Stomach Cancer) 03/2008 - 11/2005
3	Coronary Disease (Coronary Heart Disease) 01/2024 - 01/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 02/2013
3	Obesity 01/2020 - 01/2017
3	Carcinogenesis 01/2009 - 11/2007
2	Diabetes Mellitus 01/2020 - 01/2020
2	Myocardial Infarction 01/2020 - 01/2020
2	Vascular Diseases (Vascular Disease) 02/2013 - 01/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2009 - 07/2006
2	Adenocarcinoma 11/2007 - 11/2005
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	Emotional Exhaustion 01/2023
1	Occupational Stress 01/2022
1	Heart Failure 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Stroke (Strokes) 01/2020
1	Autism Spectrum Disorder 01/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Human Influenza (Influenza) 06/2012
1	Neoplasms (Cancer) 01/2009
1	Lung Neoplasms (Lung Cancer) 01/2009
1	Infections 09/2008
1	Anxiety Disorders (Anxiety Disorder) 01/2008
1	Substance-Related Disorders (Drug Abuse) 11/2005

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
5	C-Reactive ProteinIBA 01/2024 - 08/2011
4	Troponin IIBA 05/2023 - 01/2020
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2019
4	LipidsIBA 01/2023 - 10/2017
4	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009 - 11/2007
3	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2019
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2009 - 11/2007
2	Indicators and Reagents (Reagents)IBA 01/2022 - 02/2013
2	EnzymesIBA 01/2017 - 03/2008
2	SmokeIBA 01/2012 - 11/2007
2	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 09/2008 - 01/2007
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 09/2008 - 01/2007
2	histidylhistidine (His-His)IBA 11/2007 - 11/2005
2	SulfotransferasesIBA 07/2006 - 11/2005
1	Lipoprotein(a)IBA 01/2024
1	Olive OilIBA 05/2023
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2023
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	nasIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	CholesterolIBA 01/2020
1	HDL CholesterolIBA 01/2020
1	TroponinIBA 01/2020
1	NeuropeptidesIBA 01/2017
1	neuromedin UIBA 01/2017
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017
1	darapladibIBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Insulin (Novolin)FDA Link 01/2015
1	ApolipoproteinsIBA 09/2014
1	Apolipoproteins B (ApoB)IBA 09/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2013
1	Dihydrotachysterol (AT 10)IBA 02/2013
1	VaccinesIBA 06/2012
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2012
1	Interleukin-1 (Interleukin 1)IBA 09/2008
1	Cadherins (E-Cadherin)IBA 09/2008
1	CarcinogensIBA 09/2008
1	Valine (L-Valine)FDA Link 01/2008
1	Methionine (L-Methionine)FDA Link 01/2008
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2008
1	glutathione S-transferase T1IBA 03/2006
1	arginylarginine (Arg-Arg)IBA 11/2005

Therapy/Procedure

2	Mediterranean Diet 05/2023 - 10/2021
1	Protective Devices (Safety Device) 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2013
1	Therapeutics 01/2012
1	Secondary Prevention 01/2012
1	Gastrectomy 11/2005